b) Imagine at you Provide three lifestyle practices that you will suggest to them and for each practice, explain how it helps (at the cellular level) to prevent or slow the progression of atherosclerosis. Ple

Search the internet and find two articles that discuss the VA Choice program and theproblems it has had. What are these problems, and how could they be fixed?

although there are other ways to prevent DVT, do you think it's vital to advocate and require the usage of sequential compression devices to maintain blood flow and prevent blood clots? pls include references.

Discuss the role of flow cytometry in diagnosing haematological disease

Choose one example of a cardiovascular imaging technique, describe how it works, and explain how it helps diagnose and treat cardiovascular diseases. (minimum 60 words

OL UOnsənò Deductibles for Medicare Part B are adjusted higher according to: Enrollee's serverity of illness Enrollee's selcted coverage option Enrollee's average yearly income D. None of the above

Explain why hospitals readmissions are so costly for health systems or third-party payers. Explain your answer from the perspective of the three major stakeholders—providers, patients, and payers—and your analysis of the current reimbursement environment. Identify and analyze one of the leading causes of hospital readmissions over the past 5 In your opinion, outline how each of the three major stakeholders can implement a process or procedure to reduce their contribution to the readmission cycle. Describe how the transition for premodern reimbursements programs such as (P4P or DRGs) to current value-based compensation programs can potentially further reduce hospital readmission rates. Please provide a detailed example in your

Discuss the cardiac transplant procedure. Describe criteria for donors and recipients.

Discuss dietary management of cardiovascular disease patients. What are good examples of diets to follow to reduce incidence or manage the disease.

Discuss the role of anticoagulant therapy in preventing thromboembolic events.